People · Operator
Named in public records as an officer, director or promoter · active 2018–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Erasca, Inc. | — | Biotechnology | Series D+ | $183.7M | $5.2B | 2018 |
Valerie S. Harding-Start at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Valerie S. Harding-Start on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan E. Lim, M.D. | 1 | 3 |
| Jonathan Lim, M.D. | 1 | 2 |
| Pratik S. Multani, M.D. | 1 | 2 |
| James A. Bristol, Ph.D. | 1 | 2 |
| Alexander W. Casdin | 1 | 1 |
| Gary E. Yeung, CFA | 1 | 1 |
| Gary Yeung, CFA | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.